RAD51 and urinary bladder carcinoma: More specific to our research, a report has shown that mocetinostat can enhance the radiosensitivity of bladder cancer cells, which appeared to be mediated through reducing the protein levels of MRE11, RAD51, and NBS1 involved in DSB repair [29].